Researchers at the National Institutes of Health (NIH) and Oregon Health & Science University (OHSU) have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and nonhuman primates, meaning that infection may lead to shock, bleeding and multi-organ failure. According to the World Health Organization, Ebola hemorrhagic fever has a fatality rate of up to 90 percent. There is no licensed treatment or vaccine for Ebola virus infection.
Several research groups have developed experimental vaccine approaches that protect nonhuman primates from Ebola virus and the closely related Marburg virus. These approaches include vaccines based on DNA, recombinant adenovirus, virus-like particles, and human parainfluenza virus 3. But how these vaccine candidates confer protection is an area that is still being explored: Do they activate immune cells to kill the invading virus? Or do they elicit antibodies that block infection?
In this study, scientists at NIH's National Institute of Allergy and Infectious Diseases and OHSU's Vaccine & Gene Therapy Institute built on earlier work with an experimental vaccine composed of an attenuated vesicular stomatitis virus carrying a gene that codes for an Ebola virus protein. They observed how cynomolgus macaques responded to a challenge of Ebola virus before and during treatment with the vaccine and in conjunction with depleted levels of immune cells. Their results showed that important immune cells—CD4+ T cells and CD8+ T cells—had a minimal role in providing protection, while antibodies induced by the vaccine appeared to be critical to protecting the animals.
The scientists say this finding will help improve future Ebola virus vaccine development. They plan to focus their studies on what level of antibody production is needed to establish protection from Ebola virus infection in humans
WHO: Heinz Feldmann, M.D., Ph.D., chief of the Laboratory of Virology at NIAID's Rocky Mountain Laboratories. Dr. Feldmann is an expert on viral hemorrhagic fevers and emerging viruses.
ARTICLE: A Marzi et al. Antibodies are necessary for rVSV/ZEBOV-GP mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.1209591110 (2013).
NIH/National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Host Audie Cornish talks with Drew Gronewold, a hydrologist at the National Oceanic and Atmospheric Administration, about why water levels in lakes Superior, Michigan and Huron are rising.
Tornadoes in the United States are increasingly coming in swarms rather than as isolated twisters, according to a study by U.S. government meteorologists published on Thursday that illustrates another trend toward extreme weather emerging in recent years.
Just a few years ago, authors were predicting production would soon hit a peak and then decline. But since then, supplies have surged. So are the forecasters now slapping themselves in the head?
The presence of carnivores, which control herbivore numbers, helps plants without thorny defences thrive, a study of life on the savannah reveals.
The roll-out of cheap energy-saving street lights with a bluish glare has little regard for people or wildlife. There is a better way, says Jeff Hecht
In the Pacific Northwest, the salmon are running. They migrate from the ocean into rivers where they eventually spawn on gravel beds. But on the Washougal River near the border of Washington State and Oregon, Ben Tracy found the Salmon are hitching a ride.
Farmers will be able to plant types of corn and soybeans that can tolerate doses of two weedkillers. It may be one of the most significant developments the world of weedkilling in more than a decade.
From a floating house to a mobile city shaped like a giant lilypad, designers offer up some wild solutions for a wetter future
Italy will become the first country in Europe to legally require "advanced biofuels" in cars and trucks, the BBC has learned.
A US Department of Defense report says the impacts of climate change could fuel armed insurgency and challenge governments, and aims to prepare the US army for the worst